G T Ho and A J Stanley
1 Merrywather-Clarke At, Pointon JJ, Shearmen JD Robson M. Global prevalence of putative hemochromatotic mutations. J Med Genetics 1997; 34:275-278.
2 Lucotte G. Celtic origin of the C282y mutation of haemochromatosis. Blood Cell Mol Dis 1998; 24:433-438.
3 Olynk JK, Cullen DJ, Aquila S, Rossi E, Summerville L, Powell LW. A population based study of the clinical expression of the haemochromatosis gene. N Eng J Med 1999; 341:718-724.
6 Legget RA, Halliday JW, Brown NN, Bryant S, Powell LW. Prevalence of haemochromatosis amongst asymptomatic Australians. Br J Haematol 1990: 74: 525-530.
7 Edwards CQ, Griffen LM, Goldgar D, Drummond C, Skolnock MH. Prevalence of haemachromatosis amongst 11 065 presumably healthy blood donors. N Eng J Med 1988; 318; 1355-62.
8 Wiggers P, Dalho JJ, Kiaer H, et. al. Screening for haemachromatosis: prevalence amongst Danish blood donors. J Intern Med 1991 : 230 ; 265-70.
9 Tanner AR, Desai S, Lu W, Wright R. Screening for haemachromatosis. Gut 1985: 26 : 1139-40.
10 UK Haemochromatosis Consortium. A Simple genetic test identifies 90% of UK patients with haemochromatosis. Gut 1997;41:841-844.
11 Jackson HA, Carter K, Guttridge MG, Darke C, Napier JA, Ravine D and Worwood M. Haemochromatosis HFE mutations and iron status in 10 000 blood donors from South Wales. Br J Haematol 2000; 108 (5l): 47(abstract).
12 Merryweather Clarke AT, Simonsen H, Shearmen J1), Pointon JJ, Nooregaard Vedersen, Robson M. A retrospective anonymous pilot screening of newborns for HFE mutations in Scandinavian population. Human Mutat 1999 : 13(2) : 154-9.
13 Lucotte G. Celtic origin of the C282Y mutation of haemochromatosis. Blood Cell Mol Dis 1998 :24(4): 433-8.
14 Ryan E, 0 Keane C, Come J. Haemochromatosis in Ireland and HFE. Blood Cell Mol Dis 1998 : 24(4): 428-32.
15 Mercier G, Bathelier C, Lucotte G. Frqueny of C282Y mutation of haemochromatosis in 5 French population. Blood Cell Mol Dis 1998: 24(2) : 165-6.
16 Jounatte AM, Fergelott P, Rouat ML, Gendon G, Roussey M, Dergeniey Y, Feingolid J, Le Gall JY, David V. Prevalence of C282Y mutation in Britanny: Penetrance of haemochromatosis. Am Genet 1998 41(4) : 195-8.
17 Finch SC, Finch CA. Idiopathic haemochromatosis, an iron storage disease. Medicine (Baltimore) 1955: 34: 381-430
18 MacSween RM, Scott AR. Hepatic cirrhosis: a clinico-pathological review of 520 cases. J Clin Path 1973: 26: 936-42
19 MacDonald RA. Haemochromatosis and cirrhosis in different geographical areas. Am J Med Sci 1965: 249: 36-46.
20 Powell LW, Summers KM, Board PG, et. al. Expression of haemochromatosis in homozygous subj ects. Implications for early diagnosis and prevention. Gastroenterology 1990 : 98 : 1625-32.
21 Kushner JP. Screening for haemochromatosis. Gastroenterology 1995 :109; 315-6.
22 Adams PC, Gregor JC, Kertesz AE, Valberg LS. Screening blood donors for hereditary haemochromatosis: a decision analysis model based on a 30-year database. Gastroenterology 1995 ; 109 : 177-88.
23 Barton JC, Bertoli LF. Hemochromatosis: the genetic disorder of the twentyfirst century. Nat Med 1996;2:394-5.
24 Niederau C, Fischer R, Purscel A, Stremmel W, Haussinger D, Strohmeyer G. Long term survival in patients with hereditary hemochromatosis. Gastroenterology 1996; 110: 1107-1119.
25 Borwein S, Ghent CN, Valberg LS. Diagnostic efficacy of screening test for haemochromatosis. Cen Med Assoc 19: 84 ; 131 : 895-90 1.
26 Basset ML, Halliday JW, Ferris RA, Powell LW. Diagnosis of haemochromatosis in young subjects: Predictive accuracy of biochemical screening tests. Gastroenterology 1984 ; 87 : 628-633.
27 Phatak PD, Guzinan G, Woll JE et al. Cost-effectiveness of screening for hereditary haemochromatosis. Arch Intern Med 1994; 154(7):769-776.
28 Barash CI. Genetic discrimination and screening for haemochromatosis. Then and now. Genetic Testing 2000 : 4(2) : 213-18
29 Worwood M. What is the role of genetic testing in diagnosis of haemochromatosis- Ann Clin Biochem 2001;38:3A9.
30 EASI, International Consensus Conference on Haemochromatosis. J Hepatol 2000;33:485-504.
31 Tavil AS. Diagnosis and management of hemochromatosis. Hepatology 2001;33:1321-27.
32 Bhavrtani M, Lloyd D, Bhattacharya A et al. Screening for genetic haemochromatosis in blood samples with raised alanine aminotransferase. Gut 2000;46(5):707-7 10.
33 George DK, Evans RM, Crofton RW, Gunn IR. Testing for haemochromatosis in a diabetic clinic. Ann Clin Biochem 1995: 32: 521-6.
34 Phelps G, Chapman I, Hall P, Braund W, MacKinnon M. Prevalence of haemochromatosis among diabetic patients. Lancet 1989; 2: 233-4.
35 O’Brien, Barret B, Murray DM, Dinneen S, O’Sullivan DJ. Usefulness of biochemical screening of diabetic patients for haemochromatosis. Diabetes Care 1990: 1991:14:929-30.
36 Crink E, Tamas G. Screening for idiopathic haemochromatosis amonst patients with diabetes mellitus. Diabetic Care 1991:12;929-30.37.
37 Singh BM, Grinnewald RA, Press M, Muller BR, Wise PH. Prevalence of haemochromatosis amongst patients with diabetes mellitus. Diab Med 1992: 9;730-1.
38 Olynk J, Kwiatek R, Hall P, MacKinnon M, Ahern M. Screening for genetic haemochromatosis in a rheumatology clinic. Aust NZ J Med 1994: 24: 22-25.